INNOVADERM CRO IS NOW INDERO.

The Role of Technology and Innovation in Clinical Trials: A Guide for Biotech and Pharma Sponsors

Technology and innovation are transforming the landscape of clinical trials, making them more efficient, accurate, and patient-centric. This article explores the key technological advancements and innovative practices of clinical trials, with a focus on what biotech, and pharmaceutical sponsors need to know.  Leveraging Artificial Intelligence and Digital Tools  Artificial Intelligence (AI) is revolutionizing clinical trials […]

RTSM Optimization: Tips for Smooth Operations

Sponsor–Site Partnerships in Clinical Research

In this article, Veeva’s team joins us for a round table discussion on randomization and trial supply management (RTSM). We will tackle some of the most common mistakes in RTSM, share proactive steps to avoid these pitfalls, and explore real-life case studies with practical solutions. The discussion features insights from Kelly O’Brien, RTSM Senior Project […]

Reframing Process Improvement in Clinical Trials

Guillaume Gigon, VP of Technology and AI, and Robert Taylor, Associate Director, Clinical Operations at Indero, explore how Lean Six Sigma (LSS) principles – minimising waste, standardising workflows, and driving improvement through data – are being adapted from manufacturing industries to deliver clinical trials faster, more efficiently, and with greater consistency. Read More

Streamlining Clinical Trials: The Power of System Integration

integrated trial management system

System integration in clinical trial management streamlines processes and reduces the burden on research sites. As clinical trials increasingly rely on multiple platforms to collect data, integrating these systems enhances efficiency and improves the quality and reliability of the data. Despite the costs, this investment is valuable for ensuring high-quality clinical trial outcomes.  The Importance of System […]

Embracing the Power of Data Analytics and AI for Clinical Trials

Embracing the Power of Data Analytics and AI for Clinical Trials

Indero’s expertise is showcased in the article “Embracing the Power of Data Analytics and AI for Clinical Trials” by News-Medical. The article covers: The increasing adoption of digital systems in clinical trials. The article highlights the integration of artificial intelligence and machine learning to enhance data management, streamline operations, and ensure high-quality results. It discusses […]

Harnessing AI and Data Analytics

Harnessing AI and Data Analytics

The article “Harnessing Data Analytics and AI for Clinical Trials,” published by Applied Clinical Trials and authored by Guillaume Gigon, VP of Technology and AI at Indero, explores: The transformative impact of data analytics and artificial intelligence on clinical trials. The piece covers how these technologies are revolutionizing data management, enhancing operational efficiencies, and providing […]

Episode 22: Robert Taylor—Enhancing Clinical Trial Efficiency: 3 Essential CTMS Tips for Sponsors, CROs, and Sites

Innovaderm to Indero

Episode Notes We are thrilled to have Robert Taylor, Associate Director of Clinical Operations at Innovaderm, join us. Robert has an extensive background, having served in various roles such as coordinator, clinical research associate (CRA), Clinical Trial Manager, and Project Manager at small contract research organizations (CROs). Currently, he is pursuing his Lean Six Sigma […]

Episode 20: Guillaume Gigon, Christian Dansereau and Nardin Nakhla—AI-Driven Drug Development and Clinical Trials

Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Welcome to today’s episode, which delves into Artificial Intelligence (AI)-driven drug development and clinical trials. Three guest speakers will join the roundtable: Guillaume Gigon, Vice President of Technology and AI at Innovaderm; Nardin Nakhla, Co-Founder and CTO of […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.